Company news
Regenera Insights Inc. (CSE:RGEN) news
Regenera Insights Inc. news releases on 6ix. Latest, Aug 26, 2026: Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
Press releases & updates
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
August 26, 2026
Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
July 28, 2026
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
July 22, 2026
Repligen to Report Second Quarter 2026 Financial Results
July 15, 2026
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
May 22, 2026
Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report
May 20, 2026
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
May 7, 2026
Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
May 5, 2026
Repligen to Report First Quarter 2026 Financial Results
April 22, 2026
Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network
April 17, 2026
Repligen Corporation to Present at Upcoming March Conferences
March 5, 2026
Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
February 24, 2026
Repligen to Report Fourth Quarter and Full Year 2025 Financial Results
February 10, 2026
Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair
January 6, 2026
Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference
December 18, 2025
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows
December 16, 2025
Repligen Corporation to Present at Evercore Healthcare Conference
November 26, 2025
Repligen Corporation to Present at Upcoming November Conferences
November 4, 2025
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
October 28, 2025
Repligen to Report Third Quarter 2025 Financial Results
October 15, 2025
Repligen Corporation to Present at Upcoming September Conferences
August 22, 2025
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
July 31, 2025
Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
July 29, 2025
Repligen to Report Second Quarter 2025 Financial Results
July 17, 2025
Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report
May 27, 2025
Repligen Corporation to Present at William Blair Growth Conference
May 22, 2025
Repligen Corporation to Present at Upcoming May Investor Conferences
May 7, 2025
Repligen Reports First Quarter 2025 Financial Results
April 29, 2025
Repligen to Report First Quarter 2025 Financial Results
April 15, 2025
Regenera Announces Sale of Carbon RX
March 31, 2025
Regenera Announces Effective Date of Name Change
March 31, 2025
The Schall Law Firm Begins Investigation Into Claims Against Regeneron Pharmaceuticals Inc And Encourages Affected Investors To Contact Them
June 20, 2024
Investor Network: Repligen Corporation to Host Earnings Call
August 3, 2017